Brain Volume Loss During the First Year of Interferon-Beta Treatment in Multiple Sclerosis: Baseline Inflammation and Regional Brain Volume Dynamics-Reference-Cited by-同舟云学术

Brain Volume Loss During the First Year of Interferon-Beta Treatment in Multiple Sclerosis: Baseline Inflammation and Regional Brain Volume Dynamics

Published:2016-03-02 Issue:5 Volume:26 Page:532-538
ISSN:1051-2284
Container-title:Journal of Neuroimaging
language:en
Short-container-title:J Neuroimaging

Author:

Vidal-Jordana Angela¹,Sastre-Garriga Jaume¹,Pérez-Miralles Francisco¹,Pareto Deborah²,Rio Jordi¹,Auger Cristina²,Tintoré Mar¹,Rovira Alex²,Montalban Xavier¹

Affiliation:

1. Department of Neurology-Neuroimmunology and Multiple Sclerosis Centre of Catalonia (Cemcat), Hospital Universitari Vall d'Hebron; Universitat Autònoma de Barcelona; Barcelona Spain

2. Magnetic Resonance Unit, Radiology Department, Hospital Universitari Vall d'Hebron; Universitat Autònoma de Barcelona; Barcelona Spain

Publisher

Wiley

Subject

Clinical Neurology,Radiology Nuclear Medicine and imaging

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jon.12337/fullpdf

Reference29 articles.

1. The measurement and clinical relevance of brain atrophy in multiple sclerosis;Bermel R;Lancet Neurol,2006

2. The place of conventional MRI and newly emerging MRI techniques in monitoring different aspects of treatment outcome;Zivadinov;J Neurol,2008

3. Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial;Filippi;Lancet,2004

4. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis;Kappos;N Engl J Med,2010

5. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis;Cohen;N Engl J Med,2010

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early spinal cord pseudoatrophy in interferon‐beta‐treated multiple sclerosis;European Journal of Neurology;2022-11-17

2. Reduction in grey matter atrophy in patients with relapsing multiple sclerosis following treatment with cladribine tablets;European Journal of Neurology;2022-10-11

3. Brain volume change after high-dose immunosuppression and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis;Multiple Sclerosis and Related Disorders;2021-09

4. Dynamics of pseudo‐atrophy in RRMS reveals predominant gray matter compartmentalization;Annals of Clinical and Translational Neurology;2021-02-03

5. IFI35 as a biomolecular marker of neuroinflammation and treatment response in multiple sclerosis;Life Sciences;2020-10